Medical Care
Global Acquired Orphan Blood Disease Market Research Report 2024
- Jan 26, 24
- ID: 28518
- Pages: 86
- Figures: 167
- Views: 21
Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the blood. This disease is characterized by the body?s inability to produce red blood cells. Moreover, improper functioning of bone marrow also leads to lack of red blood cells in blood, which in turn results in a decrease in platelet numbers. This decrease in platelet number causes anemia and thrombosis.
The global Acquired Orphan Blood Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Acquired Orphan Blood Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acquired Orphan Blood Disease.
Report Scope
The Acquired Orphan Blood Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acquired Orphan Blood Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acquired Orphan Blood Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acorno Acorns
Alexion Pharmaceuticals
Amgen
Celgene Corporation
Eli Lilly
Sanofi
GlaxoSmithKline
Cyclacel Pharmaceuticals
Onconova Therapeutics
Incyte Corporation
CTI BioPharma
Segment by Type
Medication
Bone Marrow Transplant
Blood Transfusion
Iron Therapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acquired Orphan Blood Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Acquired Orphan Blood Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Acquired Orphan Blood Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acquired Orphan Blood Disease.
Report Scope
The Acquired Orphan Blood Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acquired Orphan Blood Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acquired Orphan Blood Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acorno Acorns
Alexion Pharmaceuticals
Amgen
Celgene Corporation
Eli Lilly
Sanofi
GlaxoSmithKline
Cyclacel Pharmaceuticals
Onconova Therapeutics
Incyte Corporation
CTI BioPharma
Segment by Type
Medication
Bone Marrow Transplant
Blood Transfusion
Iron Therapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acquired Orphan Blood Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acquired Orphan Blood Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medication
1.2.3 Bone Marrow Transplant
1.2.4 Blood Transfusion
1.2.5 Iron Therapy
1.3 Market by Application
1.3.1 Global Acquired Orphan Blood Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acquired Orphan Blood Disease Market Perspective (2019-2030)
2.2 Acquired Orphan Blood Disease Growth Trends by Region
2.2.1 Global Acquired Orphan Blood Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Acquired Orphan Blood Disease Historic Market Size by Region (2019-2024)
2.2.3 Acquired Orphan Blood Disease Forecasted Market Size by Region (2025-2030)
2.3 Acquired Orphan Blood Disease Market Dynamics
2.3.1 Acquired Orphan Blood Disease Industry Trends
2.3.2 Acquired Orphan Blood Disease Market Drivers
2.3.3 Acquired Orphan Blood Disease Market Challenges
2.3.4 Acquired Orphan Blood Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acquired Orphan Blood Disease Players by Revenue
3.1.1 Global Top Acquired Orphan Blood Disease Players by Revenue (2019-2024)
3.1.2 Global Acquired Orphan Blood Disease Revenue Market Share by Players (2019-2024)
3.2 Global Acquired Orphan Blood Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acquired Orphan Blood Disease Revenue
3.4 Global Acquired Orphan Blood Disease Market Concentration Ratio
3.4.1 Global Acquired Orphan Blood Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acquired Orphan Blood Disease Revenue in 2023
3.5 Acquired Orphan Blood Disease Key Players Head office and Area Served
3.6 Key Players Acquired Orphan Blood Disease Product Solution and Service
3.7 Date of Enter into Acquired Orphan Blood Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acquired Orphan Blood Disease Breakdown Data by Type
4.1 Global Acquired Orphan Blood Disease Historic Market Size by Type (2019-2024)
4.2 Global Acquired Orphan Blood Disease Forecasted Market Size by Type (2025-2030)
5 Acquired Orphan Blood Disease Breakdown Data by Application
5.1 Global Acquired Orphan Blood Disease Historic Market Size by Application (2019-2024)
5.2 Global Acquired Orphan Blood Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Acquired Orphan Blood Disease Market Size (2019-2030)
6.2 North America Acquired Orphan Blood Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Acquired Orphan Blood Disease Market Size by Country (2019-2024)
6.4 North America Acquired Orphan Blood Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acquired Orphan Blood Disease Market Size (2019-2030)
7.2 Europe Acquired Orphan Blood Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Acquired Orphan Blood Disease Market Size by Country (2019-2024)
7.4 Europe Acquired Orphan Blood Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acquired Orphan Blood Disease Market Size (2019-2030)
8.2 Asia-Pacific Acquired Orphan Blood Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Acquired Orphan Blood Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific Acquired Orphan Blood Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acquired Orphan Blood Disease Market Size (2019-2030)
9.2 Latin America Acquired Orphan Blood Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Acquired Orphan Blood Disease Market Size by Country (2019-2024)
9.4 Latin America Acquired Orphan Blood Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acquired Orphan Blood Disease Market Size (2019-2030)
10.2 Middle East & Africa Acquired Orphan Blood Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Acquired Orphan Blood Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa Acquired Orphan Blood Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acorno Acorns
11.1.1 Acorno Acorns Company Detail
11.1.2 Acorno Acorns Business Overview
11.1.3 Acorno Acorns Acquired Orphan Blood Disease Introduction
11.1.4 Acorno Acorns Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.1.5 Acorno Acorns Recent Development
11.2 Alexion Pharmaceuticals
11.2.1 Alexion Pharmaceuticals Company Detail
11.2.2 Alexion Pharmaceuticals Business Overview
11.2.3 Alexion Pharmaceuticals Acquired Orphan Blood Disease Introduction
11.2.4 Alexion Pharmaceuticals Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.2.5 Alexion Pharmaceuticals Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Acquired Orphan Blood Disease Introduction
11.3.4 Amgen Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.3.5 Amgen Recent Development
11.4 Celgene Corporation
11.4.1 Celgene Corporation Company Detail
11.4.2 Celgene Corporation Business Overview
11.4.3 Celgene Corporation Acquired Orphan Blood Disease Introduction
11.4.4 Celgene Corporation Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.4.5 Celgene Corporation Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Detail
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Acquired Orphan Blood Disease Introduction
11.5.4 Eli Lilly Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.5.5 Eli Lilly Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Acquired Orphan Blood Disease Introduction
11.6.4 Sanofi Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.6.5 Sanofi Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Acquired Orphan Blood Disease Introduction
11.7.4 GlaxoSmithKline Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.7.5 GlaxoSmithKline Recent Development
11.8 Cyclacel Pharmaceuticals
11.8.1 Cyclacel Pharmaceuticals Company Detail
11.8.2 Cyclacel Pharmaceuticals Business Overview
11.8.3 Cyclacel Pharmaceuticals Acquired Orphan Blood Disease Introduction
11.8.4 Cyclacel Pharmaceuticals Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.8.5 Cyclacel Pharmaceuticals Recent Development
11.9 Onconova Therapeutics
11.9.1 Onconova Therapeutics Company Detail
11.9.2 Onconova Therapeutics Business Overview
11.9.3 Onconova Therapeutics Acquired Orphan Blood Disease Introduction
11.9.4 Onconova Therapeutics Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.9.5 Onconova Therapeutics Recent Development
11.10 Incyte Corporation
11.10.1 Incyte Corporation Company Detail
11.10.2 Incyte Corporation Business Overview
11.10.3 Incyte Corporation Acquired Orphan Blood Disease Introduction
11.10.4 Incyte Corporation Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.10.5 Incyte Corporation Recent Development
11.11 CTI BioPharma
11.11.1 CTI BioPharma Company Detail
11.11.2 CTI BioPharma Business Overview
11.11.3 CTI BioPharma Acquired Orphan Blood Disease Introduction
11.11.4 CTI BioPharma Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.11.5 CTI BioPharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acquired Orphan Blood Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medication
1.2.3 Bone Marrow Transplant
1.2.4 Blood Transfusion
1.2.5 Iron Therapy
1.3 Market by Application
1.3.1 Global Acquired Orphan Blood Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acquired Orphan Blood Disease Market Perspective (2019-2030)
2.2 Acquired Orphan Blood Disease Growth Trends by Region
2.2.1 Global Acquired Orphan Blood Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Acquired Orphan Blood Disease Historic Market Size by Region (2019-2024)
2.2.3 Acquired Orphan Blood Disease Forecasted Market Size by Region (2025-2030)
2.3 Acquired Orphan Blood Disease Market Dynamics
2.3.1 Acquired Orphan Blood Disease Industry Trends
2.3.2 Acquired Orphan Blood Disease Market Drivers
2.3.3 Acquired Orphan Blood Disease Market Challenges
2.3.4 Acquired Orphan Blood Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acquired Orphan Blood Disease Players by Revenue
3.1.1 Global Top Acquired Orphan Blood Disease Players by Revenue (2019-2024)
3.1.2 Global Acquired Orphan Blood Disease Revenue Market Share by Players (2019-2024)
3.2 Global Acquired Orphan Blood Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acquired Orphan Blood Disease Revenue
3.4 Global Acquired Orphan Blood Disease Market Concentration Ratio
3.4.1 Global Acquired Orphan Blood Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acquired Orphan Blood Disease Revenue in 2023
3.5 Acquired Orphan Blood Disease Key Players Head office and Area Served
3.6 Key Players Acquired Orphan Blood Disease Product Solution and Service
3.7 Date of Enter into Acquired Orphan Blood Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acquired Orphan Blood Disease Breakdown Data by Type
4.1 Global Acquired Orphan Blood Disease Historic Market Size by Type (2019-2024)
4.2 Global Acquired Orphan Blood Disease Forecasted Market Size by Type (2025-2030)
5 Acquired Orphan Blood Disease Breakdown Data by Application
5.1 Global Acquired Orphan Blood Disease Historic Market Size by Application (2019-2024)
5.2 Global Acquired Orphan Blood Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Acquired Orphan Blood Disease Market Size (2019-2030)
6.2 North America Acquired Orphan Blood Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Acquired Orphan Blood Disease Market Size by Country (2019-2024)
6.4 North America Acquired Orphan Blood Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acquired Orphan Blood Disease Market Size (2019-2030)
7.2 Europe Acquired Orphan Blood Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Acquired Orphan Blood Disease Market Size by Country (2019-2024)
7.4 Europe Acquired Orphan Blood Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acquired Orphan Blood Disease Market Size (2019-2030)
8.2 Asia-Pacific Acquired Orphan Blood Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Acquired Orphan Blood Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific Acquired Orphan Blood Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acquired Orphan Blood Disease Market Size (2019-2030)
9.2 Latin America Acquired Orphan Blood Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Acquired Orphan Blood Disease Market Size by Country (2019-2024)
9.4 Latin America Acquired Orphan Blood Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acquired Orphan Blood Disease Market Size (2019-2030)
10.2 Middle East & Africa Acquired Orphan Blood Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Acquired Orphan Blood Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa Acquired Orphan Blood Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acorno Acorns
11.1.1 Acorno Acorns Company Detail
11.1.2 Acorno Acorns Business Overview
11.1.3 Acorno Acorns Acquired Orphan Blood Disease Introduction
11.1.4 Acorno Acorns Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.1.5 Acorno Acorns Recent Development
11.2 Alexion Pharmaceuticals
11.2.1 Alexion Pharmaceuticals Company Detail
11.2.2 Alexion Pharmaceuticals Business Overview
11.2.3 Alexion Pharmaceuticals Acquired Orphan Blood Disease Introduction
11.2.4 Alexion Pharmaceuticals Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.2.5 Alexion Pharmaceuticals Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Acquired Orphan Blood Disease Introduction
11.3.4 Amgen Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.3.5 Amgen Recent Development
11.4 Celgene Corporation
11.4.1 Celgene Corporation Company Detail
11.4.2 Celgene Corporation Business Overview
11.4.3 Celgene Corporation Acquired Orphan Blood Disease Introduction
11.4.4 Celgene Corporation Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.4.5 Celgene Corporation Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Detail
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Acquired Orphan Blood Disease Introduction
11.5.4 Eli Lilly Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.5.5 Eli Lilly Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Acquired Orphan Blood Disease Introduction
11.6.4 Sanofi Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.6.5 Sanofi Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Acquired Orphan Blood Disease Introduction
11.7.4 GlaxoSmithKline Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.7.5 GlaxoSmithKline Recent Development
11.8 Cyclacel Pharmaceuticals
11.8.1 Cyclacel Pharmaceuticals Company Detail
11.8.2 Cyclacel Pharmaceuticals Business Overview
11.8.3 Cyclacel Pharmaceuticals Acquired Orphan Blood Disease Introduction
11.8.4 Cyclacel Pharmaceuticals Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.8.5 Cyclacel Pharmaceuticals Recent Development
11.9 Onconova Therapeutics
11.9.1 Onconova Therapeutics Company Detail
11.9.2 Onconova Therapeutics Business Overview
11.9.3 Onconova Therapeutics Acquired Orphan Blood Disease Introduction
11.9.4 Onconova Therapeutics Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.9.5 Onconova Therapeutics Recent Development
11.10 Incyte Corporation
11.10.1 Incyte Corporation Company Detail
11.10.2 Incyte Corporation Business Overview
11.10.3 Incyte Corporation Acquired Orphan Blood Disease Introduction
11.10.4 Incyte Corporation Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.10.5 Incyte Corporation Recent Development
11.11 CTI BioPharma
11.11.1 CTI BioPharma Company Detail
11.11.2 CTI BioPharma Business Overview
11.11.3 CTI BioPharma Acquired Orphan Blood Disease Introduction
11.11.4 CTI BioPharma Revenue in Acquired Orphan Blood Disease Business (2019-2024)
11.11.5 CTI BioPharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Acquired Orphan Blood Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Medication
Table 3. Key Players of Bone Marrow Transplant
Table 4. Key Players of Blood Transfusion
Table 5. Key Players of Iron Therapy
Table 6. Global Acquired Orphan Blood Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Acquired Orphan Blood Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Acquired Orphan Blood Disease Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Acquired Orphan Blood Disease Market Share by Region (2019-2024)
Table 10. Global Acquired Orphan Blood Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Acquired Orphan Blood Disease Market Share by Region (2025-2030)
Table 12. Acquired Orphan Blood Disease Market Trends
Table 13. Acquired Orphan Blood Disease Market Drivers
Table 14. Acquired Orphan Blood Disease Market Challenges
Table 15. Acquired Orphan Blood Disease Market Restraints
Table 16. Global Acquired Orphan Blood Disease Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Acquired Orphan Blood Disease Market Share by Players (2019-2024)
Table 18. Global Top Acquired Orphan Blood Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Orphan Blood Disease as of 2023)
Table 19. Ranking of Global Top Acquired Orphan Blood Disease Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Acquired Orphan Blood Disease Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Acquired Orphan Blood Disease Product Solution and Service
Table 23. Date of Enter into Acquired Orphan Blood Disease Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Acquired Orphan Blood Disease Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Acquired Orphan Blood Disease Revenue Market Share by Type (2019-2024)
Table 27. Global Acquired Orphan Blood Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Acquired Orphan Blood Disease Revenue Market Share by Type (2025-2030)
Table 29. Global Acquired Orphan Blood Disease Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Acquired Orphan Blood Disease Revenue Market Share by Application (2019-2024)
Table 31. Global Acquired Orphan Blood Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Acquired Orphan Blood Disease Revenue Market Share by Application (2025-2030)
Table 33. North America Acquired Orphan Blood Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Acquired Orphan Blood Disease Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Acquired Orphan Blood Disease Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Acquired Orphan Blood Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Acquired Orphan Blood Disease Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Acquired Orphan Blood Disease Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Acquired Orphan Blood Disease Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Acquired Orphan Blood Disease Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Acquired Orphan Blood Disease Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Acquired Orphan Blood Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Acquired Orphan Blood Disease Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Acquired Orphan Blood Disease Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Acquired Orphan Blood Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Acquired Orphan Blood Disease Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Acquired Orphan Blood Disease Market Size by Country (2025-2030) & (US$ Million)
Table 48. Acorno Acorns Company Detail
Table 49. Acorno Acorns Business Overview
Table 50. Acorno Acorns Acquired Orphan Blood Disease Product
Table 51. Acorno Acorns Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 52. Acorno Acorns Recent Development
Table 53. Alexion Pharmaceuticals Company Detail
Table 54. Alexion Pharmaceuticals Business Overview
Table 55. Alexion Pharmaceuticals Acquired Orphan Blood Disease Product
Table 56. Alexion Pharmaceuticals Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 57. Alexion Pharmaceuticals Recent Development
Table 58. Amgen Company Detail
Table 59. Amgen Business Overview
Table 60. Amgen Acquired Orphan Blood Disease Product
Table 61. Amgen Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 62. Amgen Recent Development
Table 63. Celgene Corporation Company Detail
Table 64. Celgene Corporation Business Overview
Table 65. Celgene Corporation Acquired Orphan Blood Disease Product
Table 66. Celgene Corporation Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 67. Celgene Corporation Recent Development
Table 68. Eli Lilly Company Detail
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Acquired Orphan Blood Disease Product
Table 71. Eli Lilly Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 72. Eli Lilly Recent Development
Table 73. Sanofi Company Detail
Table 74. Sanofi Business Overview
Table 75. Sanofi Acquired Orphan Blood Disease Product
Table 76. Sanofi Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 77. Sanofi Recent Development
Table 78. GlaxoSmithKline Company Detail
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Acquired Orphan Blood Disease Product
Table 81. GlaxoSmithKline Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Cyclacel Pharmaceuticals Company Detail
Table 84. Cyclacel Pharmaceuticals Business Overview
Table 85. Cyclacel Pharmaceuticals Acquired Orphan Blood Disease Product
Table 86. Cyclacel Pharmaceuticals Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 87. Cyclacel Pharmaceuticals Recent Development
Table 88. Onconova Therapeutics Company Detail
Table 89. Onconova Therapeutics Business Overview
Table 90. Onconova Therapeutics Acquired Orphan Blood Disease Product
Table 91. Onconova Therapeutics Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 92. Onconova Therapeutics Recent Development
Table 93. Incyte Corporation Company Detail
Table 94. Incyte Corporation Business Overview
Table 95. Incyte Corporation Acquired Orphan Blood Disease Product
Table 96. Incyte Corporation Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 97. Incyte Corporation Recent Development
Table 98. CTI BioPharma Company Detail
Table 99. CTI BioPharma Business Overview
Table 100. CTI BioPharma Acquired Orphan Blood Disease Product
Table 101. CTI BioPharma Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 102. CTI BioPharma Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acquired Orphan Blood Disease Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Acquired Orphan Blood Disease Market Share by Type: 2023 VS 2030
Figure 3. Medication Features
Figure 4. Bone Marrow Transplant Features
Figure 5. Blood Transfusion Features
Figure 6. Iron Therapy Features
Figure 7. Global Acquired Orphan Blood Disease Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Acquired Orphan Blood Disease Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Acquired Orphan Blood Disease Report Years Considered
Figure 13. Global Acquired Orphan Blood Disease Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Acquired Orphan Blood Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Acquired Orphan Blood Disease Market Share by Region: 2023 VS 2030
Figure 16. Global Acquired Orphan Blood Disease Market Share by Players in 2023
Figure 17. Global Top Acquired Orphan Blood Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Orphan Blood Disease as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Acquired Orphan Blood Disease Revenue in 2023
Figure 19. North America Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Acquired Orphan Blood Disease Market Share by Country (2019-2030)
Figure 21. United States Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Acquired Orphan Blood Disease Market Share by Country (2019-2030)
Figure 25. Germany Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Acquired Orphan Blood Disease Market Share by Region (2019-2030)
Figure 33. China Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Acquired Orphan Blood Disease Market Share by Country (2019-2030)
Figure 41. Mexico Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Acquired Orphan Blood Disease Market Share by Country (2019-2030)
Figure 45. Turkey Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Acorno Acorns Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 48. Alexion Pharmaceuticals Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 49. Amgen Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 50. Celgene Corporation Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 51. Eli Lilly Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 52. Sanofi Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 54. Cyclacel Pharmaceuticals Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 55. Onconova Therapeutics Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 56. Incyte Corporation Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 57. CTI BioPharma Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Acquired Orphan Blood Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Medication
Table 3. Key Players of Bone Marrow Transplant
Table 4. Key Players of Blood Transfusion
Table 5. Key Players of Iron Therapy
Table 6. Global Acquired Orphan Blood Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Acquired Orphan Blood Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Acquired Orphan Blood Disease Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Acquired Orphan Blood Disease Market Share by Region (2019-2024)
Table 10. Global Acquired Orphan Blood Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Acquired Orphan Blood Disease Market Share by Region (2025-2030)
Table 12. Acquired Orphan Blood Disease Market Trends
Table 13. Acquired Orphan Blood Disease Market Drivers
Table 14. Acquired Orphan Blood Disease Market Challenges
Table 15. Acquired Orphan Blood Disease Market Restraints
Table 16. Global Acquired Orphan Blood Disease Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Acquired Orphan Blood Disease Market Share by Players (2019-2024)
Table 18. Global Top Acquired Orphan Blood Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Orphan Blood Disease as of 2023)
Table 19. Ranking of Global Top Acquired Orphan Blood Disease Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Acquired Orphan Blood Disease Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Acquired Orphan Blood Disease Product Solution and Service
Table 23. Date of Enter into Acquired Orphan Blood Disease Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Acquired Orphan Blood Disease Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Acquired Orphan Blood Disease Revenue Market Share by Type (2019-2024)
Table 27. Global Acquired Orphan Blood Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Acquired Orphan Blood Disease Revenue Market Share by Type (2025-2030)
Table 29. Global Acquired Orphan Blood Disease Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Acquired Orphan Blood Disease Revenue Market Share by Application (2019-2024)
Table 31. Global Acquired Orphan Blood Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Acquired Orphan Blood Disease Revenue Market Share by Application (2025-2030)
Table 33. North America Acquired Orphan Blood Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Acquired Orphan Blood Disease Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Acquired Orphan Blood Disease Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Acquired Orphan Blood Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Acquired Orphan Blood Disease Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Acquired Orphan Blood Disease Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Acquired Orphan Blood Disease Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Acquired Orphan Blood Disease Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Acquired Orphan Blood Disease Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Acquired Orphan Blood Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Acquired Orphan Blood Disease Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Acquired Orphan Blood Disease Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Acquired Orphan Blood Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Acquired Orphan Blood Disease Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Acquired Orphan Blood Disease Market Size by Country (2025-2030) & (US$ Million)
Table 48. Acorno Acorns Company Detail
Table 49. Acorno Acorns Business Overview
Table 50. Acorno Acorns Acquired Orphan Blood Disease Product
Table 51. Acorno Acorns Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 52. Acorno Acorns Recent Development
Table 53. Alexion Pharmaceuticals Company Detail
Table 54. Alexion Pharmaceuticals Business Overview
Table 55. Alexion Pharmaceuticals Acquired Orphan Blood Disease Product
Table 56. Alexion Pharmaceuticals Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 57. Alexion Pharmaceuticals Recent Development
Table 58. Amgen Company Detail
Table 59. Amgen Business Overview
Table 60. Amgen Acquired Orphan Blood Disease Product
Table 61. Amgen Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 62. Amgen Recent Development
Table 63. Celgene Corporation Company Detail
Table 64. Celgene Corporation Business Overview
Table 65. Celgene Corporation Acquired Orphan Blood Disease Product
Table 66. Celgene Corporation Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 67. Celgene Corporation Recent Development
Table 68. Eli Lilly Company Detail
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Acquired Orphan Blood Disease Product
Table 71. Eli Lilly Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 72. Eli Lilly Recent Development
Table 73. Sanofi Company Detail
Table 74. Sanofi Business Overview
Table 75. Sanofi Acquired Orphan Blood Disease Product
Table 76. Sanofi Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 77. Sanofi Recent Development
Table 78. GlaxoSmithKline Company Detail
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Acquired Orphan Blood Disease Product
Table 81. GlaxoSmithKline Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Cyclacel Pharmaceuticals Company Detail
Table 84. Cyclacel Pharmaceuticals Business Overview
Table 85. Cyclacel Pharmaceuticals Acquired Orphan Blood Disease Product
Table 86. Cyclacel Pharmaceuticals Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 87. Cyclacel Pharmaceuticals Recent Development
Table 88. Onconova Therapeutics Company Detail
Table 89. Onconova Therapeutics Business Overview
Table 90. Onconova Therapeutics Acquired Orphan Blood Disease Product
Table 91. Onconova Therapeutics Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 92. Onconova Therapeutics Recent Development
Table 93. Incyte Corporation Company Detail
Table 94. Incyte Corporation Business Overview
Table 95. Incyte Corporation Acquired Orphan Blood Disease Product
Table 96. Incyte Corporation Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 97. Incyte Corporation Recent Development
Table 98. CTI BioPharma Company Detail
Table 99. CTI BioPharma Business Overview
Table 100. CTI BioPharma Acquired Orphan Blood Disease Product
Table 101. CTI BioPharma Revenue in Acquired Orphan Blood Disease Business (2019-2024) & (US$ Million)
Table 102. CTI BioPharma Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acquired Orphan Blood Disease Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Acquired Orphan Blood Disease Market Share by Type: 2023 VS 2030
Figure 3. Medication Features
Figure 4. Bone Marrow Transplant Features
Figure 5. Blood Transfusion Features
Figure 6. Iron Therapy Features
Figure 7. Global Acquired Orphan Blood Disease Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Acquired Orphan Blood Disease Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Acquired Orphan Blood Disease Report Years Considered
Figure 13. Global Acquired Orphan Blood Disease Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Acquired Orphan Blood Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Acquired Orphan Blood Disease Market Share by Region: 2023 VS 2030
Figure 16. Global Acquired Orphan Blood Disease Market Share by Players in 2023
Figure 17. Global Top Acquired Orphan Blood Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Orphan Blood Disease as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Acquired Orphan Blood Disease Revenue in 2023
Figure 19. North America Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Acquired Orphan Blood Disease Market Share by Country (2019-2030)
Figure 21. United States Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Acquired Orphan Blood Disease Market Share by Country (2019-2030)
Figure 25. Germany Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Acquired Orphan Blood Disease Market Share by Region (2019-2030)
Figure 33. China Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Acquired Orphan Blood Disease Market Share by Country (2019-2030)
Figure 41. Mexico Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Acquired Orphan Blood Disease Market Share by Country (2019-2030)
Figure 45. Turkey Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Acquired Orphan Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Acorno Acorns Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 48. Alexion Pharmaceuticals Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 49. Amgen Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 50. Celgene Corporation Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 51. Eli Lilly Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 52. Sanofi Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 54. Cyclacel Pharmaceuticals Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 55. Onconova Therapeutics Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 56. Incyte Corporation Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 57. CTI BioPharma Revenue Growth Rate in Acquired Orphan Blood Disease Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232